GnRH antagonist for patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer in fresh cycles

被引:3
作者
Zhai, Xiang-Hong [1 ,2 ]
Zhang, Ping [2 ,3 ]
Wu, Feng-Xia [4 ]
Wang, An-Cong [2 ,3 ]
Liu, Pei-Shu [5 ]
机构
[1] Linyi Peoples Hosp, Dept Obstet & Gynecol, Linyi Hlth Sch, Linyi 276003, Shandong, Peoples R China
[2] Linyi Peoples Hosp, Dept Resp Med, 27 Jiefang Rd, Linyi 276003, Shandong, Peoples R China
[3] Linyi Peoples Hosp, Dept Obstet & Ginecol, Linyi 276003, Shandong, Peoples R China
[4] Shandong Univ, Dept Anat, Jinan 250012, Shandong, Peoples R China
[5] Shandong Univ, Qilu Hosp, Dept Obstet & Ginecol, Jinan 250012, Shandong, Peoples R China
关键词
polycystic ovary syndrome; in vitro fertilization and embryo transfer; gonadotrophin-releasing hormone antagonist; ovarian hyperstimulation syndrome; clinical pregnancy; fresh cycle; ENDOMETRIAL RECEPTIVITY; ANALOG; IVF; GONADOTROPINS; METAANALYSIS; THICKNESS;
D O I
10.3892/etm.2017.4309
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The aim of the present study was to evaluate the influence of a gonadotropin-releasing hormone (GnRH) antagonist compared with a GnRH agonist on the in vitro fertilization cycle outcome in patients with polycystic ovary syndrome. The outcomes of pregnancy were evaluated. The area under the curve (AUC) of the receiver operating characteristic (ROC) curve was also used to evaluate whether the endometrial thickness (cm) and estradiol (E-2) level (pg/ml) on the day of human chorionic gonadotropin (hCG) administration (the hCG day) had the best sensitivity and specificity for predicting a clinical pregnancy. The results demonstrated that there were significant differences in the E-2 and progesterone levels between the two treatment groups on the hCG day. Furthermore, the mean number of total oocytes retrieved, mean number of 2 pronuclei oocytes, mean number of oocytes cleaved (P< 0.05), mean number of embryos available (P= 0.022) and mean number of embryos transferred (P= 0.014) were significantly different. Additionally, the rates of ectopic pregnancy (P= 0.984) and ovarian hyperstimulation syndrome (P= 0.976) did not differ significantly between the treatment groups. Although the biochemical pregnancy (P= 0.592), clinical pregnancy (P= 0.617) and live birth (P= 0.365) rates were lower with the GnRH antagonist than with the GnRH agonist, there were no significant differences in the outcomes between the two groups. Analysis of the influence of endometrial thickness with respect to the clinical pregnancy using the ROC (AUC) method revealed that when the best cutoff of 9.75 cm was used, the sensitivity was 62.5%, the specificity was 43.1% and the AUC was 0.53. Additionally, the Youden index was 0.056. Analysis of the influence of the E-2 level on the hCG day on clinical pregnancy, using the ROC (AUC) method showed that the best cutoff was 2,984.5 pg/ml, which had a sensitivity of 68.8% and specificity of 52.9%, while the AUC was 0.573 (with a Youden index of 0.217). Furthermore, the results demonstrated that neither the endometrial thickness nor the E-2 level on the hCG day had the best sensitivity and specificity for predicting a clinical pregnancy.
引用
收藏
页码:3097 / 3102
页数:6
相关论文
共 22 条
[1]   Gonadotrophin-releasing hormone antagonists for assisted conception: A Cochrane Review [J].
Al-Inany, H. G. ;
Abou-Setta, A. M. ;
Aboulghar, M. .
REPRODUCTIVE BIOMEDICINE ONLINE, 2007, 14 (05) :640-649
[2]   Gonadotrophin-releasing hormone antagonists for assisted reproductive technology [J].
Al-Inany, Hesham G. ;
Youssef, Mohamed A. F. M. ;
Aboulghar, Mohamed ;
Broekmans, Frank ;
Sterrenburg, Monique ;
Smit, Janine ;
Abou-Setta, Ahmed M. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (05)
[3]   GnRH antagonists are safer than agonists: an update of a Cochrane review [J].
Al-Inany, Hesham G. ;
Youssef, Mohamed A. F. M. ;
Aboulghar, Mohamed ;
Broekmans, Frank ;
Sterrenburg, Monique ;
Smit, Janine ;
Abou-Setta, Ahmed M. .
HUMAN REPRODUCTION UPDATE, 2011, 17 (04) :435-435
[4]  
Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI [10.1093/humupd/dmq020, 10.1093/humupd/dmp048]
[5]   The hormonal control of endometrial receptivity:: estrogen (E2) and progesterone [J].
de Ziegler, D ;
Fanchin, R ;
de Moustier, B ;
Bulletti, C .
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1998, 39 (1-2) :149-166
[6]   Inflammation and Implantation [J].
Dekel, Nava ;
Gnainsky, Yulia ;
Granot, Irit ;
Mor, Gil .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2010, 63 (01) :17-21
[7]   Mitochondrial distribution and activity in human mature oocytes: gonadotropin-releasing hormone agonist versus antagonist for pituitary down-regulation [J].
Dell'Aquila, Maria Elena ;
Ambruosi, Barbara ;
De Santis, Teresa ;
Cho, Yoon Sung .
FERTILITY AND STERILITY, 2009, 91 (01) :249-255
[8]   IN-VITRO FERTILIZATION IN COMPLETELY NATURAL CYCLES [J].
FAHY, UM ;
CAHILL, DJ ;
WARDLE, PG ;
HULL, MGR .
HUMAN REPRODUCTION, 1995, 10 (03) :572-575
[9]   The role of ultrasonography in the evaluation of endometrial receptivity following assisted reproductive treatments: A critical review [J].
Friedler, S ;
Schenker, JG ;
Herman, A ;
Lewin, A .
HUMAN REPRODUCTION UPDATE, 1996, 2 (04) :323-335
[10]   GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis [J].
Griesinger, Georg .
REPRODUCTIVE BIOMEDICINE ONLINE, 2006, 13 (05) :628-638